Nrc Health (NRC) Depreciation & Amortization (CF) (2010 - 2026)

Nrc Health (NRC) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $2.2 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 40.66% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $8.3 million (up 34.89% YoY), and the FY2025 full-year result was $7.6 million, up 26.6% from the prior year.
• Depreciation & Amortization (CF) climbed to $2.2 million in Q1 2026, from $2.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.2 million in Q3 2025 to a low of $1.3 million in Q2 2022.
• A 5-year average of $1.6 million and a median of $1.5 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) fell 0.58% in 2024 and surged 41.98% in 2025, its largest moves.
• Tracing NRC's Depreciation & Amortization (CF) over 5 years: stood at $1.3 million in 2022, then increased by 10.34% to $1.4 million in 2023, then advanced by 6.01% to $1.5 million in 2024, then surged by 41.49% to $2.1 million in 2025, then grew by 1.12% to $2.2 million in 2026.
• Business Quant data shows NRC's Depreciation & Amortization (CF) at $2.2 million in Q1 2026, $2.1 million in Q4 2025, and $2.2 million in Q3 2025.